Cargando…
Precision medicine: an approach to R&D for delivering superior medicines to patients
Pharmaceutical R&D productivity has declined over the last decade despite increasing investments. Recent trends, however, indicate a potential reversal of this trend fueled by a wave of new biologics, vaccines and highly selective NCEs directed against targets validated by human genetics, focus...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3567426/ https://www.ncbi.nlm.nih.gov/pubmed/23369459 http://dx.doi.org/10.1186/2001-1326-1-7 |
_version_ | 1782258703417737216 |
---|---|
author | Dolsten, Mikael Søgaard, Morten |
author_facet | Dolsten, Mikael Søgaard, Morten |
author_sort | Dolsten, Mikael |
collection | PubMed |
description | Pharmaceutical R&D productivity has declined over the last decade despite increasing investments. Recent trends, however, indicate a potential reversal of this trend fueled by a wave of new biologics, vaccines and highly selective NCEs directed against targets validated by human genetics, focus on new disease areas including orphan and genetic diseases and more precise tailoring of medicines to their target populations. |
format | Online Article Text |
id | pubmed-3567426 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Springer |
record_format | MEDLINE/PubMed |
spelling | pubmed-35674262013-02-08 Precision medicine: an approach to R&D for delivering superior medicines to patients Dolsten, Mikael Søgaard, Morten Clin Transl Med Editorial Pharmaceutical R&D productivity has declined over the last decade despite increasing investments. Recent trends, however, indicate a potential reversal of this trend fueled by a wave of new biologics, vaccines and highly selective NCEs directed against targets validated by human genetics, focus on new disease areas including orphan and genetic diseases and more precise tailoring of medicines to their target populations. Springer 2012-05-30 /pmc/articles/PMC3567426/ /pubmed/23369459 http://dx.doi.org/10.1186/2001-1326-1-7 Text en Copyright ©2012 Dolsten and Sogaard; licensee Springer. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Editorial Dolsten, Mikael Søgaard, Morten Precision medicine: an approach to R&D for delivering superior medicines to patients |
title | Precision medicine: an approach to R&D for delivering superior medicines to patients |
title_full | Precision medicine: an approach to R&D for delivering superior medicines to patients |
title_fullStr | Precision medicine: an approach to R&D for delivering superior medicines to patients |
title_full_unstemmed | Precision medicine: an approach to R&D for delivering superior medicines to patients |
title_short | Precision medicine: an approach to R&D for delivering superior medicines to patients |
title_sort | precision medicine: an approach to r&d for delivering superior medicines to patients |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3567426/ https://www.ncbi.nlm.nih.gov/pubmed/23369459 http://dx.doi.org/10.1186/2001-1326-1-7 |
work_keys_str_mv | AT dolstenmikael precisionmedicineanapproachtordfordeliveringsuperiormedicinestopatients AT søgaardmorten precisionmedicineanapproachtordfordeliveringsuperiormedicinestopatients |